About CNSDose
CNSDose is a company based in Melbourne (Australia) founded in 2015 was acquired by Incite Health in February 2023.. CNSDose has raised $1.01 million across 2 funding rounds from investors including Pitchblak, Melbourne Accelerator Program and CNSDose. CNSDose operates in a competitive market with competitors including MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock, among others.
- Headquarter Melbourne, Australia
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.01 M (USD)
in 2 rounds
-
Latest Funding Round
$1 M (USD), Seed
Jul 13, 2016
-
Investors
Pitchblak
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Incite Health
(Feb 15, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CNSDose
CNSDose has successfully raised a total of $1.01M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in July 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.0M
-
First Round
First Round
(24 May 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2016 | Amount | Seed - CNSDose | Valuation | Pitchblak |
|
| May, 2016 | Amount | Seed - CNSDose | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CNSDose
CNSDose has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Pitchblak, Melbourne Accelerator Program and CNSDose. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Startup founders are supported through accelerator and pre-accelerator programs.
|
Founded Year | Domain | Location | |
|
Genetic testing for personalized mental health medication is provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CNSDose
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CNSDose
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cnsdose Comparisons
Competitors of CNSDose
CNSDose operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Genetic testing products for health risks and traits are offered.
|
|
| domain | founded_year | HQ Location |
Personalized cancer diagnostics are developed using genomic big data analysis.
|
|
| domain | founded_year | HQ Location |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CNSDose
When was CNSDose founded?
CNSDose was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is CNSDose located?
CNSDose is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
Is CNSDose a funded company?
CNSDose is a funded company, having raised a total of $1.01M across 2 funding rounds to date. The company's 1st funding round was a Seed of $14.45K, raised on May 24, 2016.
What does CNSDose do?
CNSDose was founded in 2015 in Melbourne, Australia, within the pharmacogenomics sector. Tools are provided to evaluate hepatic metabolism and efflux transporters via genomics, determining anti-depressant efficiency across the blood-brain barrier. Saliva samples from patients are processed at affiliated labs, with reports accessed by doctors through a secure cloud server for prescribing decisions. Operations focus on personalized treatment support in mental health care.
Who are the top competitors of CNSDose?
CNSDose's top competitors include Foundation Medicine, MedGenome and Personalis.
Who are CNSDose's investors?
CNSDose has 3 investors. Key investors include Pitchblak, Melbourne Accelerator Program, and CNSDose.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.